NEWS
Discover the latest updates on our firm and team here.
Keyword search
Sort by
Default
Input time DESC
Input time ASC
-
RuiMin advising AstraZeneca in acquisition of Gracell Biotechnologies Inc. furthering the AstraZeneca Cell Therapy
AstraZeneca (LSE/STO/Nasdaq: AZN) has recently entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, Nasdaq: GRCL). The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies.
12 January 2024 -
Representative cases of RuiMin's global transaction team in the 2022-2023
This article will introduce some representative cases that RuiMin's global transaction team participated in the past 2022-2023 year.
12 July 2023